Clinical Trials Directory

Trials / Unknown

UnknownNCT01205074

¹³C-Methacetin Breath Test (MBT) Methodology Study

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
Sponsor
Hadassah Medical Organization · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Several factors will be tested to see if they have an influence on the methacetin breath test results. Each one of the factors has been raised as a possible source of distortion of the MBT result. I. Variability between same tests on same subject MBT. Repeatability will be tested in both healthy individuals and patients with chronic liver disease. II. COPD - Chronic obstructive pulmonary disease is a leading cause of death worldwide, and can potentially have an effect on the MBT since the breath test is based on CO2 production and these subjects may have abnormal CO2 production. III. Smoking- 13C Methacetin is metabolized by healthy hepatocytes reflecting hepatic microsomal function of CYP1A2, and smoking may cause induction of CYP1A2. Furthermore, internal preliminary data has shown signs that there is an influence of smoking on the MBT ranges. IV. Age- Empirical data on several hundred subjects with chronic liver disease has shown that age is a significant factor in determining the probability of disease severity and preliminary data in normal subjects have shown changes in MBT with age.. Therefore, the effect of age has to be elucidated in an orderly fashion. V. CYP450 1A2 Inhibitors- Several drugs and food items inhibit CYP450 1A2 and may affect the MBT. VI. Alcohol - Alcohol ingestion leads to induction of hepatic CYP and at a later stage to inhibition due to liver damage. Acute alcohol ingestion may therefore effect MBT results. VII. Beta-blockers - beta blocker are affecting portal hypertension and may affect hepatic blood flow and thereby the outcome of the methacetin breath test.

Conditions

Interventions

TypeNameDescription
DEVICE13C Methacetin Breath Test
DIETARY_SUPPLEMENTGrape fruit juice
DRUGNon selective beta blocker - Propranolol
DIETARY_SUPPLEMENTEthanol

Timeline

Start date
2010-09-01
First posted
2010-09-20
Last updated
2012-08-28

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01205074. Inclusion in this directory is not an endorsement.